Livingston Group Asset Management CO operating as Southport Capital Management increased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.2% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 5,733 shares of the healthcare conglomerate’s stock after purchasing an additional 123 shares during the period. Livingston Group Asset Management CO operating as Southport Capital Management’s holdings in UnitedHealth Group were worth $1,685,000 as of its most recent filing with the SEC.
A number of other institutional investors have also bought and sold shares of the stock. Capital City Trust Co. FL raised its position in shares of UnitedHealth Group by 1.1% in the 4th quarter. Capital City Trust Co. FL now owns 3,557 shares of the healthcare conglomerate’s stock valued at $1,046,000 after buying an additional 38 shares in the last quarter. Cypress Capital Group lifted its position in shares of UnitedHealth Group by 0.5% during the 4th quarter. Cypress Capital Group now owns 7,154 shares of the healthcare conglomerate’s stock worth $2,103,000 after buying an additional 39 shares during the last quarter. Clear Harbor Asset Management LLC boosted its stake in UnitedHealth Group by 0.6% in the third quarter. Clear Harbor Asset Management LLC now owns 6,573 shares of the healthcare conglomerate’s stock valued at $1,428,000 after buying an additional 40 shares in the last quarter. Smith Moore & CO. boosted its stake in UnitedHealth Group by 1.3% in the second quarter. Smith Moore & CO. now owns 3,156 shares of the healthcare conglomerate’s stock valued at $770,000 after buying an additional 41 shares in the last quarter. Finally, Cleararc Capital Inc. grew its position in UnitedHealth Group by 0.3% in the third quarter. Cleararc Capital Inc. now owns 12,943 shares of the healthcare conglomerate’s stock valued at $2,813,000 after acquiring an additional 42 shares during the last quarter. Institutional investors and hedge funds own 85.44% of the company’s stock.
Several research analysts have commented on the company. JPMorgan Chase & Co. boosted their target price on UnitedHealth Group from $276.00 to $361.00 and gave the stock an “overweight” rating in a research note on Friday, December 20th. Jefferies Financial Group downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and reduced their price target for the company from $300.00 to $235.00 in a research note on Thursday, October 10th. ValuEngine raised shares of UnitedHealth Group from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd. BMO Capital Markets reiterated a “market perform” rating and set a $310.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, December 4th. Finally, Argus reissued a “buy” rating and issued a $340.00 price objective on shares of UnitedHealth Group in a research note on Thursday, December 19th. Five investment analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and a consensus target price of $313.50.
NYSE UNH traded down $0.27 on Thursday, hitting $296.15. The company’s stock had a trading volume of 1,064,377 shares, compared to its average volume of 2,752,997. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.67. UnitedHealth Group Inc has a 1-year low of $208.07 and a 1-year high of $300.00. The company’s 50-day moving average is $288.46 and its 200 day moving average is $255.03. The firm has a market cap of $273.08 billion, a PE ratio of 22.99, a PEG ratio of 1.37 and a beta of 0.65.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Wednesday, January 15th. The healthcare conglomerate reported $3.90 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.77 by $0.13. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The firm had revenue of $60.90 billion during the quarter, compared to analysts’ expectations of $61.17 billion. During the same period in the prior year, the company posted $3.28 EPS. The company’s revenue was up 4.3% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Inc will post 14.98 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a yield of 1.46%. The ex-dividend date of this dividend was Friday, December 6th. UnitedHealth Group’s dividend payout ratio is presently 33.54%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: How to start trading in the forex market?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.